Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1373-6. doi: 10.1007/s00259-013-2469-9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Antibodies, Bispecific / pharmacokinetics*
  • Heterocyclic Compounds, 1-Ring / pharmacokinetics*
  • Humans
  • Male
  • Oligopeptides / pharmacokinetics*
  • Positron-Emission Tomography*
  • Prostatic Neoplasms / diagnostic imaging*
  • Radioimmunotherapy*
  • Radiopharmaceuticals / pharmacokinetics*

Substances

  • Antibodies, Bispecific
  • DOTA-tyrosyl-lysyl(histaminyl-succinyl-glycyl)-glutamyl-lysyl(histaminyl-succinyl-glycyl)amide
  • Heterocyclic Compounds, 1-Ring
  • Oligopeptides
  • Radiopharmaceuticals